Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs114499642
rs114499642
G 0.700 GeneticVariation GWASCAT Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. 29907492

2018

dbSNP: rs74412765
rs74412765
T 0.700 GeneticVariation GWASCAT Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. 29907492

2018

dbSNP: rs76872642
rs76872642
A 0.700 GeneticVariation GWASCAT Genome-wide association analyses identified loci associated with attention/vigilance (rs830786 within HNF4G), verbal memory (rs67017972 near NDUFS4), and reasoning/problem solving (rs76872642 within HDAC9). 29907492

2018

dbSNP: rs2142694
rs2142694
0.700 GeneticVariation GWASCAT Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). 27046643

2016

dbSNP: rs9771228
rs9771228
0.700 GeneticVariation GWASCAT Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). 27046643

2016

dbSNP: rs17108533
rs17108533
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs17126180
rs17126180
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs17689437
rs17689437
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs17706989
rs17706989
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs2286720
rs2286720
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs2833556
rs2833556
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs3753242
rs3753242
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011

dbSNP: rs4611189
rs4611189
0.700 GeneticVariation GWASCAT Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 21107309

2011